ISRCTN88307799已完成1 期
Phase I trial: Fortrea code: 8476207 [The full scientific title will be published within 30 months after the end of the trial]
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •The HRA has approved deferral of publication of trial details. The full details will be added to the study record within 30 months after the trial has ended.
排除标准
- •The HRA has approved deferral of publication of trial details. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
已完成
1 期
Phase I trial code: PKM17308ISRCTN49135540Sanofi-Aventis Recherche & Développement12
已完成
Unknown
Phase 1 trial: CA38951Healthy volunteersISRCTN46343886Millicent Pharma Limited36
已完成
1 期
Phase I trial Quotient Code: QSC207682The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.Not SpecifiedISRCTN10750305Constellation Pharmaceuticals (United States)8
已完成
1 期
Phase 1 trial: Labcorp code 8501022Healthy volunteersISRCTN13265717Albireo (Sweden)76
已完成
1 期
Phase I trial: Labcorp Drug Development Study: 8479217The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN14340698Bergenbio ASA6